Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,887,528
-
Total 13F shares
-
15,325,061
-
Share change
-
+421,207
-
Total reported value
-
$38,287,272
-
Put/Call ratio
-
13%
-
Price per share
-
$2.50
-
Number of holders
-
47
-
Value change
-
+$856,837
-
Number of buys
-
14
-
Number of sells
-
28
Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) as of Q1 2025
As of 31 Mar 2025 Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,325,061 shares of stock of the company.
Largest 10 holders included TCG Crossover Management, LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, STEMPOINT CAPITAL LP, COMMODORE CAPITAL LP, SPHERA FUNDS MANAGEMENT LTD., JPMORGAN CHASE & CO, Ikarian Capital, LLC, DIADEMA PARTNERS LP, and ADAR1 Capital Management, LLC.
This table shows 47 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.